PT Kalbe Farma Tbk. (IDX:KLBF)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
920.00
+20.00 (2.22%)
May 8, 2026, 4:10 PM WIB
Market Cap41.63T -20.5%
Revenue (ttm)36.21T +9.6%
Net Income3.62T +7.7%
EPS79.64 +9.1%
Shares Out45.25B
PE Ratio11.55
Forward PE11.10
Dividend36.00 (3.91%)
Ex-Dividend DateJun 4, 2025
Volume140,237,800
Average Volume58,158,675
Open900.00
Previous Close900.00
Day's Range880.00 - 930.00
52-Week Range850.00 - 1,600.00
Beta0.01
RSI48.31
Earnings DateMay 13, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as ... [Read more]

Sector Healthcare
Founded 1966
Employees 12,835
Stock Exchange Indonesia Stock Exchange
Ticker Symbol KLBF
Full Company Profile

Financial Performance

In 2025, PT Kalbe Farma Tbk.'s revenue was 35.32 trillion, an increase of 8.27% compared to the previous year's 32.63 trillion. Earnings were 3.66 trillion, an increase of 13.09%.

Financial Statements